Nurse Practitioner · Seattle, WA
NPI
1578068094
Since 2018
Specialty
Nurse Practitioner
Code 363L00000X
Group practices
1
Medicare group memberships
Hospitals
1
Hospital affiliations
1100 9th Ave
Seattle, WA, 98101
Phone (206) 341-1111
Groups this clinician bills Medicare through
Medicare paid, 2024
$20K
307 services
Medicare patients, 2024
118
Average age 69
Drug cost, 2024
$1.7M
1,102 prescriptions
Company payments, 2025
$330
From 4 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Jonathan R Medina-Beckwith was code 99214 (office e&m - established), 135 times for 76 patients. In total Jonathan R Medina-Beckwith billed 307 services in 11 codes, and Medicare paid $20K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2025-04-23.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Facility | 135 | 76 | $65.03 | $8,780 |
| 99215 Office E&M - Established | Facility | 64 | 50 | $97.72 | $6,254 |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Facility | 43 | 34 | $12.42 | $534 |
| 99214 Office E&M - Established | Office | 21 | 19 | $95.74 | $2,011 |
By year: 2022 $12K for 168 services; 2023 $12K for 185 services; 2024 $20K for 307 services.
Medicare prescription drug claims, 2024
In 2024, the drug Jonathan R Medina-Beckwith prescribed most often to Medicare patients was Camzyos (Mavacamten), with 181 prescriptions and refills. In total Jonathan R Medina-Beckwith wrote 1,102 Medicare prescriptions that cost $1.7M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Camzyos Mavacamten | 181 | 183 | 21 | $1.5M |
| Metoprolol Succinate Generic | 152 | 424 | 54 | $2,307 |
| Eliquis Apixaban | 69 | 146 | 21 | $82K |
| Atorvastatin Calcium Generic | 64 | 188 | 23 | $596 |
| Rosuvastatin Calcium Generic | 57 | 164 | 19 | $1,195 |
| Furosemide Generic | 55 | 141 | 23 | $279 |
| Amlodipine Besylate Generic | 49 | 140 | 15 | $383 |
| Potassium Chloride Generic | 41 | 117 | 14 | $1,236 |
| Losartan Potassium Generic | 40 | 120 | 16 | $365 |
| Lisinopril Generic | 37 | 113 | 11 | $415 |
| Verapamil Er Verapamil Hcl | 32 | 94 | 11 | $896 |
| Spironolactone Generic | 27 | 71 | 14 | $171 |
| Torsemide Generic | 25 | 71 | Under 11 | $703 |
| Carvedilol Generic | 25 | 70 | Under 11 | $246 |
| Diltiazem 24hr Er (Cd) Diltiazem Hcl | 22 | 58 | Under 11 | $531 |
Brand drugs: 332 claims; generic drugs: 770 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Jonathan R Medina-Beckwith $330 ($330 in general payments such as food, travel and fees) from 4 companies. The largest payer was E.R. Squibb & Sons, L.L.C. with $251.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.